Tight glycaemic control improves ICU survival.
|
For every 29 patients given intensive insulin
therapy, to keep glucose 4.4-6.1 mmol.l-1, compared to standard
therapy, one less patient dies in ICU. (95% CI 17 to 101)
Level of Evidence 1+ |
Citation:
Intensive Insulin Therapy in Critically Ill Patients. NEJM 2001; 345 (19):
1359-1367.
Lead author's name and fax: Prof Greet Van den Berghe, Department of
Intensive Care, University Hospital Gasthuisberg, University of Leuven.
greta.vandenberghe@med.kuleuven.ac.be
Three-part
Clinical Question: Among critically ill ICU patients, does intensive insulin
therapy to maintain relative normoglycaemia, (compared to usual therapy) reduce
morbidity and mortality?
Search Terms: 1. critical care2. insulin3. RCT filter
The Study:
Single-blinded randomised controlled trial with intention-to-treat.
The Study Patients: All patients requiring mechanical ventilation,
admitted to a predominantly surgical ICU in Belgium. 62% had cardiac surgery.
13% had diabetes. Median APACHE II=9. Median TISS=43. Randomised at ICU
admission. All patients fed continuously.
Control group (N = 783; 783 analysed): Insulin infusion commenced if
blood glucose > 11.9 mmol/L and maintained between 10.0 - 11.1 mmol/L. BM
checked 1-4 hrly. Dose adjusted according to algorithm and advice of study
physician not involved in patient care.
Experimental group (N = 765; 765 analysed): Insulin infusion commenced if
blood glucose >6.1 mmol/L and maintained between 4.4 - 6.1 mmol/L. BM checked
1-4 hrly. Dose adjusted according to algorithm and advice of study physician not
involved in patient care.
The Evidence:
|
Outcome |
Time to
Outcome |
CER |
EER |
RRR |
ARR |
NNT |
|
Death |
In ICU |
0.080 |
0.046 |
43% |
0.034 |
29 |
|
95% Confidence
Intervals: |
12% to 73% |
0.010 to
0.058 |
17 to 101 |
|
Death |
In
Hospital |
0.109 |
0.072 |
34% |
0.037 |
27 |
|
95% Confidence
Intervals: |
8% to 60% |
0.009 to
0.065 |
15 to 118 |
Comments:
1. 62%
post-cardiac surgery. Although differences in survival apparent in patients with
long rather than short ICU stays.
2. This
study is being repeated in a general ICU.
3. GKI
infusions reduce morbidity and mortality after MI and CABG.
4. Lower
mean blood glucose reduced mortality rate. In contrast, higher daily insulin
dose increased mortality rate. See Critical Care Medicine 2003; 31:359-366.
5. Insulin
is a cheap drug compared to rhAPC.
6. Mortality
in this mixed surgical medical ICU was lower than we experience. The case mix
was different, look at the APACHE scores. However, sepsis is common in our
practice, and death due to sepsis is a more common event per 100 patients in our
practice, we may need to treat fewer patients to save a life.
Appraised by: Kevin Rooney Department of Anaesthesia & Intensive Care
Medicine, Royal Alexandra Hospital, Paisley; 07 October 2002 Email:
kd.rooney@virgin.net Kill or Update By: October 2006
Printer friendly
format
|